In this QCast episode, Jullia and Tom discuss CDASH standards and conformance in clinical data management, focusing on how standardised data collection supports cleaner CRF design, clearer metadata and smoother SDTM mapping. CDASH sits at the point of capture, so decisions made during CRF and eCRF design can affect data review, reconciliation, programming and submission long before analysis begins.
The discussion also looks at common pressure points for study teams, including late application of standards, inconsistent field naming, over-reliance on local CRF preferences and the added complexity of ePRO, eCOA, eSource and external vendor data. When CDASH is applied thoughtfully, it gives teams a consistent structure without removing the need for protocol-specific judgement.
CDASH starts before SDTM mapping
CDASH supports standardised data collection at the point where site-entered or system-captured data first enters the study database. While SDTM organises collected data for submission, CDASH helps teams ask the right questions in a consistent way before that stage. This makes CRF design, field naming and later mapping easier to control.
CDASH starts before SDTM mapping
CDASH supports standardised data collection at the point where site-entered or system-captured data first enters the study database. While SDTM organises collected data for submission, CDASH helps teams ask the right questions in a consistent way before that stage. This makes CRF design, field naming and later mapping easier to control.
Standardised collection helps reduce ambiguity
Clear CRF questions, controlled terminology and consistent field structures can reduce confusion for sites and limit unnecessary variation in the data. This is especially relevant when studies involve repeated lab collections, dosing changes, safety follow-up, protocol deviations, ePRO, eCOA, eSource or vendor data. CDASH cannot remove every query, but it can reduce ambiguity at the point of entry.
Jullia
Welcome to QCast, the show where biometric expertise meets data-driven dialogue. I’m Jullia.
Tom
I’m Tom, and in each episode, we dive into the methodologies, case studies, regulatory shifts, and industry trends shaping modern drug development.
Jullia
Whether you’re in biotech, pharma or life sciences, we’re here to bring you practical insights straight from a leading biometrics CRO. Let’s get started.
Tom
Today we’re talking about CDASH standards and conformance in clinical data management. It sounds quite technical on the surface, but it sits very close to everyday study delivery, doesn’t it?
Jullia
It does. It affects how data is collected at site, how CRFs and eCRFs are designed, how fields are named, and how easily the data can later move into SDTM for review and submission.
Tom
For anyone who knows CDISC and SDTM, but is less familiar with CDASH, where would you place it in the data flow?
Jullia
I’d place CDASH right at the point of collection. CDASH stands for Clinical Data Acquisition Standards Harmonization, and it gives a standard way to collect clinical trial data across studies and sponsors. While SDTM is about how collected data is organised for submission, CDASH is about asking the right questions in a consistent way before the data reaches that stage.
Tom
So it’s upstream of SDTM rather than a replacement for it.
Jullia
Exactly. A lot of downstream issues begin with small inconsistencies upstream. If adverse event information, concomitant medication details, or lab-related fields are collected differently study by study, the programming, mapping, review and reconciliation work becomes harder than it needs to be.
Tom
Can you give an example?
Jullia
Take adverse events for one. A study might ask for an adverse event start date in one format, another might split date and time differently, whilst another might use different field naming conventions altogether. The clinical meaning may be similar, but the data management and programming teams now have to interpret and map those variations.
And that sounds like a small difference until it appears across hundreds or thousands of records. CDASH helps reduce that variation by giving teams common collection standards for domains such as adverse events, demographics, medical history, concomitant medications, protocol deviations, labs and vital signs.
Tom
A common misconception might be that standards make CRF design rigid. Is that fair, or does CDASH allow room for the protocol?
Jullia
CDASH is not meant to make every CRF look identical regardless of the study. A protocol still drives what needs to be collected, and there may be study-specific prompts, conditional fields, therapeutic area needs, or local considerations. CDASH gives structure so those choices are made deliberately rather than by habit or preference. The same applies when a sponsor has its own CRF library, edit checks or metadata standards. CDASH gives those internal standards a recognised industry reference point.
So really, it’s more so a way of making sure collection decisions are traceable and defensible. If you can trace how a field was collected, named, how it maps to SDTM, and why it appears on the CRF, then review becomes cleaner. That matters for internal data review, sponsor oversight, regulatory review and reuse of data across programmes.
Tom
Where does conformance come in?
Jullia
Conformance is about whether the study is applying the CDASH standard in a way that preserves the intended link with SDTM and standard data collection. At a basic level, it asks whether the CRF includes the relevant recommended or conditional fields for the domains needed by the study. It also looks at naming conventions, metadata and whether variables can be traced from the data capture system through to SDTM.
Really, it’s the difference between having the right content and implementing it properly. Now you can have a CRF that broadly collects the right data, but if naming is inconsistent, metadata is unclear, or fields do not map cleanly, the benefit is reduced. Conformance is where CDM, standards governance, programming and study operations need to line up.
Tom
When would that alignment usually happen? Is it mostly during database build?
Jullia
Ideally it starts before then. During CRF design, teams should be looking at the protocol, the required assessments, expected SDTM domains and sponsor standards. If a visit schedule includes repeated lab collections, dose changes, safety follow-up visits or diary entries, those collection points need to be thought through before the EDC is configured.
A poorly designed field can create repeated queries, unclear site responses, awkward derivations or manual review steps that could have been avoided. But CDASH helps make the collection instrument clearer for the site and cleaner for the teams using the data later.
Tom
What resources do teams usually rely on when they’re trying to apply CDASH properly?
Jullia
The main resources are the CDASH Model and the CDASH Implementation Guide, often called CDASHIG. The implementation guide gives domain-level guidance and examples for applying the standards to CRFs. Teams may also use CDISC Controlled Terminology, because standard values and code lists help reduce inconsistency in collected responses. For disease-specific needs, Therapeutic Area User Guides can also help teams handle data that is relevant to particular indications.
Tom
Could you give an example of where controlled terminology changes the day-to-day data management picture?
Jullia
A simple example is a field where the site selects a response from a defined list rather than typing free text. If a dosing change reason, lab status, or yes-no response is collected with controlled options, the data is easier to clean and review. Free text may still be needed in some places, but using standard terminology where appropriate reduces avoidable variation.
Tom
Where do teams most often run into problems with CDASH conformance?
Jullia
One common issue is applying CDASH too late, after the CRF has already been designed around local preferences. Another is treating the standard as a checklist rather than thinking about protocol-specific relevance. Teams can also struggle when ePRO, eCOA, eSource or external vendor data enters the picture, because those data models are not always designed around the same assumptions as the EDC.
Tom
That digital data point is interesting. ePRO and eSource are often talked about as efficiency gains, but they can introduce more variation too, don’t they?
Jullia
They can. With ePRO or eCOA, the data model may depend on the provider, the instrument and the sponsor’s configuration choices. With eSource, data may come directly from electronic health records or other systems, which can create variation before the data reaches the EDC. CDASH principles help teams think about standardised collection and mapping even when the source system is less traditional.
Tom
What about site experience? Does CDASH help as well?
Jullia
It can, when it’s applied thoughtfully. Clear CRF questions, consistent field structure and sensible completion instructions can reduce confusion for site staff. For example, if protocol deviation handling is captured in a consistent way, the site is less likely to enter partial or ambiguous information, and the data manager is less likely to send repeated queries.
And while CDASH cannot remove all queries, because trials are complex and data will always need review, it can reduce ambiguity at the point of entry.
Really, CDASH works at the point of collection, so it affects data quality long before analysis begins. Conformance depends on both the content of the CRF and the way the standard is implemented through metadata and naming. And digital data sources make standardised thinking more important, because variation can enter the study through more channels.
Tom
For a clinical development team planning a new study, what would be a sensible first step?
Jullia
Start by aligning the protocol, CRF design, SDTM expectations and sponsor standards before build decisions are locked in. Bring data management and programming into the conversation early, especially for complex assessments, vendor data, ePRO, labs, dosing changes and safety follow-up. The earlier the structure is agreed, the less rework the team is likely to face later.
Tom
And if a study is already live?
Jullia
Then the focus shifts to control and documentation. You may not be able to redesign everything, but you can check whether the most important fields are mapped clearly, whether naming and metadata are understandable, and whether recurring data issues point back to collection design.
So I guess the final takeaway is for teams to think about discipline at the point of capture. CDASH helps teams collect clinical trial data in a consistent, traceable way, so the data can support SDTM mapping, regulatory review and reliable analysis.
With that, we’ve come to the end of today’s episode on CDASH standards and conformance in clinical data management. If you found this discussion useful, don’t forget to subscribe to QCast so you never miss an episode and share it with a colleague. And if you’d like to learn more about how Quanticate supports data-driven solutions in clinical trials, head to our website or get in touch.
Tom
Thanks for tuning in, and we’ll see you in the next episode.
QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.
Subscribe to QCast on Apple Podcasts or Spotify to never miss an episode.